Items where Author is "Zampedri, L"
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.
Article
Athauda, Dilan, Maclagan, Kate, Budnik, Natalia, Zampedri, Luca, Hibbert, Steve, Aviles-Olmos, Iciar, Chowdhury, Kashfia, Skene, Simon S., Limousin, Patricia and Foltynie, Thomas (2018) Post hoc analysis of the Exenatide-PD trial-Factors that predict response European Journal of Neuroscience, 49 (3). pp. 410-421.
Athauda, Dilan, Maclagan, Kate, Budnik, Natalia, Zampedri, Luca, Hibbert, Steve, Skene, Simon S., Chowdhury, Kashfia, Aviles-Olmos, Iciar, Limousin, Patricia and Foltynie, Thomas (2018) What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis Journal of Parkinson's Disease, 8 (2). pp. 247-258.
Athauda, D, Maclagan, K, Skene, S, Bajwa-Joseph, M, Letchford, D, Chowdhury, K, Hibbert, S, Budnik, N, Zampedri, L, Dickson, J, Li, Y, Aviles-Olmos,, I, Warner, T T, Limousin, P, Lees, A J, Greig, N H, Tebbs, S and Foltynie, T (2017) Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. The Lancet, 390 (10103). pp1664-1675.